Procter & Gamble Health Limited announced its quarterly results on September 15, 2020. Consolidated net revenue for the quarter ended June 30, 2020, stood at Rs201.16cr, which declined by 13.9% yoy from Rs233.63cr compared to the same quarter previous year.
EBITDA stood at Rs53.09cr for the quarter ended June 30, 2020, that decreased by 2.66% yoy. For the quarter ended June 30, 2019, it had posted EBITDA of Rs54.54cr. EBITDA margin for the latest quarter was at 26.39% that increased by 3.05% yoy against the same quarter, the previous year.
The consolidated net profit for quarter ended June 2020 came in at Rs48.86cr that increased by 10.84% yoy, as compared to Rs44.08cr it had posted in the same quarter last year. The net profit margin also increased by 5.42% yoy in the same period.
Company has now transitioned from a January – December fiscal year to a July – June fiscal year aligned with the fiscal year followed by P&G globally.
The share price of company closed at Rs5,655.5 with gains of 7.71% in today’s session on BSE.
|
Particulars |
June 30, 2020 (Rs in cr) |
June 30, 2019 (Rs in cr) |
% VAR |
|
Net Revenue |
201.16 |
233.63 |
-13.90 |
|
Operating Profit |
53.09 |
54.54 |
-2.66 |
|
Net Profit |
48.86 |
44.08 |
10.84 |
|
EBITDAM% |
26.39 |
23.34 |
3.05 |
|
PATM% |
24.29 |
18.87 |
5.42 |
Related Tags:
